BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 17709281)

  • 1. Pre-erythrocytic stage malaria vaccines: time for a change in path.
    Druilhe P; Barnwell JW
    Curr Opin Microbiol; 2007 Aug; 10(4):371-8. PubMed ID: 17709281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preerythrocytic malaria vaccine development.
    Mikolajczak SA; Aly AS; Kappe SH
    Curr Opin Infect Dis; 2007 Oct; 20(5):461-6. PubMed ID: 17762778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
    Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
    J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of protective immunity induced by irradiation-attenuated sporozoites and its implication for pre-erythrocytic malaria vaccine research].
    Xu WY
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Feb; 27(1):70-4. PubMed ID: 19459506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically modified Plasmodium highlights the potential of whole parasite vaccine strategies.
    Good MF
    Trends Immunol; 2005 Jun; 26(6):295-7. PubMed ID: 15922944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine development against malaria.
    Matuschewski K
    Curr Opin Immunol; 2006 Aug; 18(4):449-57. PubMed ID: 16765576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination against malaria with live parasites.
    Rénia L; Grüner AC; Mauduit M; Snounou G
    Expert Rev Vaccines; 2006 Aug; 5(4):473-81. PubMed ID: 16989628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New concepts in vaccine development in malaria.
    Kanoi BN; Egwang TG
    Curr Opin Infect Dis; 2007 Jun; 20(3):311-6. PubMed ID: 17471043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective immunity to pre-erythrocytic stage malaria.
    Schwenk RJ; Richie TL
    Trends Parasitol; 2011 Jul; 27(7):306-14. PubMed ID: 21435951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.
    Mueller AK; Labaied M; Kappe SH; Matuschewski K
    Nature; 2005 Jan; 433(7022):164-7. PubMed ID: 15580261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A whole parasite vaccine to control the blood stages of Plasmodium: the case for lateral thinking.
    Good MF
    Trends Parasitol; 2011 Aug; 27(8):335-40. PubMed ID: 21514227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective immunity against malaria liver stage after vaccination with live parasites.
    Rénia L
    Parasite; 2008 Sep; 15(3):379-83. PubMed ID: 18814710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole parasite vaccination approaches for prevention of malaria infection.
    Butler NS; Vaughan AM; Harty JT; Kappe SH
    Trends Immunol; 2012 May; 33(5):247-54. PubMed ID: 22405559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination using normal live sporozoites under drug treatment.
    Rénia L; Grüner AC; Mauduit M; Snounou G
    Methods Mol Biol; 2013; 923():567-76. PubMed ID: 22990805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination using radiation- or genetically attenuated live sporozoites.
    Vaughan AM; Kappe SH
    Methods Mol Biol; 2013; 923():549-66. PubMed ID: 22990804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effects of radiation on the safety and protective efficacy of an attenuated Plasmodium yoelii sporozoite malaria vaccine.
    Chattopadhyay R; Conteh S; Li M; James ER; Epstein JE; Hoffman SL
    Vaccine; 2009 Jun; 27(27):3675-80. PubMed ID: 19071177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines against malaria - an update.
    Matuschewski K; Mueller AK
    FEBS J; 2007 Sep; 274(18):4680-7. PubMed ID: 17824954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel approaches to whole sporozoite vaccination against malaria.
    Bijker EM; Borrmann S; Kappe SH; Mordmüller B; Sack BK; Khan SM
    Vaccine; 2015 Dec; 33(52):7462-8. PubMed ID: 26469716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection.
    Douradinha B; van Dijk MR; Ataide R; van Gemert GJ; Thompson J; Franetich JF; Mazier D; Luty AJ; Sauerwein R; Janse CJ; Waters AP; Mota MM
    Int J Parasitol; 2007 Nov; 37(13):1511-9. PubMed ID: 17604034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages.
    Nardin EH; Nussenzweig RS
    Annu Rev Immunol; 1993; 11():687-727. PubMed ID: 8476576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.